vs
Automatic Data Processing（ADP）与NEOGENOMICS INC（NEO）财务数据对比。点击上方公司名可切换其他公司
Automatic Data Processing的季度营收约是NEOGENOMICS INC的28.2倍（$5.4B vs $190.2M）。NEOGENOMICS INC同比增速更快（10.6% vs 6.2%）。过去两年NEOGENOMICS INC的营收复合增速更高（10.3% vs 1.0%）
ADP是总部位于美国新泽西州罗斯兰的跨国企业，为全球各行业客户提供云基人力资源管理、薪资核算处理、专业雇主组织（PEO）等领域的专业服务，是全球人力资源服务领域的知名头部供应商。
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
ADP vs NEO — 直观对比
营收规模更大
ADP
是对方的28.2倍
$190.2M
营收增速更快
NEO
高出4.4%
6.2%
两年增速更快
NEO
近两年复合增速
1.0%
损益表 — Q2 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $5.4B | $190.2M |
| 净利润 | $1.1B | — |
| 毛利率 | 46.1% | 43.8% |
| 营业利润率 | 25.8% | -7.1% |
| 净利率 | 19.8% | — |
| 营收同比 | 6.2% | 10.6% |
| 净利润同比 | 10.3% | — |
| 每股收益（稀释后） | $2.62 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADPNEO
| Q4 25 | $5.4B | $190.2M | ||
| Q3 25 | $5.2B | $187.8M | ||
| Q2 25 | $5.1B | $181.3M | ||
| Q1 25 | $5.6B | $168.0M | ||
| Q4 24 | $5.0B | $172.0M | ||
| Q3 24 | $4.8B | $167.8M | ||
| Q2 24 | $4.8B | $164.5M | ||
| Q1 24 | $5.3B | $156.2M |
净利润ADPNEO
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.0B | $-27.1M | ||
| Q2 25 | $910.7M | $-45.1M | ||
| Q1 25 | $1.2B | $-25.9M | ||
| Q4 24 | $963.2M | — | ||
| Q3 24 | $956.3M | $-17.7M | ||
| Q2 24 | $829.3M | $-18.6M | ||
| Q1 24 | $1.2B | $-27.1M |
毛利率ADPNEO
| Q4 25 | 46.1% | 43.8% | ||
| Q3 25 | 45.2% | 42.8% | ||
| Q2 25 | 45.1% | 42.6% | ||
| Q1 25 | 47.7% | 43.6% | ||
| Q4 24 | 45.7% | 44.9% | ||
| Q3 24 | 45.5% | 44.6% | ||
| Q2 24 | 44.8% | 44.1% | ||
| Q1 24 | 47.3% | 41.9% |
营业利润率ADPNEO
| Q4 25 | 25.8% | -7.1% | ||
| Q3 25 | 25.3% | -14.4% | ||
| Q2 25 | 23.2% | -26.3% | ||
| Q1 25 | 29.2% | -16.6% | ||
| Q4 24 | 25.0% | -10.7% | ||
| Q3 24 | 25.6% | -12.6% | ||
| Q2 24 | 22.8% | -13.3% | ||
| Q1 24 | 29.4% | -19.6% |
净利率ADPNEO
| Q4 25 | 19.8% | — | ||
| Q3 25 | 19.6% | -14.4% | ||
| Q2 25 | 17.8% | -24.9% | ||
| Q1 25 | 22.5% | -15.4% | ||
| Q4 24 | 19.1% | — | ||
| Q3 24 | 19.8% | -10.5% | ||
| Q2 24 | 17.4% | -11.3% | ||
| Q1 24 | 22.6% | -17.3% |
每股收益（稀释后）ADPNEO
| Q4 25 | $2.62 | — | ||
| Q3 25 | $2.49 | — | ||
| Q2 25 | $2.23 | — | ||
| Q1 25 | $3.06 | — | ||
| Q4 24 | $2.35 | — | ||
| Q3 24 | $2.34 | — | ||
| Q2 24 | $2.01 | — | ||
| Q1 24 | $2.88 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5B | $159.6M |
| 总债务越低越好 | — | $341.9M |
| 股东权益账面价值 | $6.4B | $836.6M |
| 总资产 | $84.6B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.41× |
8季度趋势，按日历期对齐
现金及短期投资ADPNEO
| Q4 25 | $2.5B | $159.6M | ||
| Q3 25 | $7.9B | $164.1M | ||
| Q2 25 | $7.8B | $154.7M | ||
| Q1 25 | $2.7B | $346.2M | ||
| Q4 24 | $2.2B | $367.0M | ||
| Q3 24 | $7.3B | $362.0M | ||
| Q2 24 | $3.3B | $355.1M | ||
| Q1 24 | $3.3B | $331.9M |
总债务ADPNEO
| Q4 25 | — | $341.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $541.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ADPNEO
| Q4 25 | $6.4B | $836.6M | ||
| Q3 25 | $6.4B | $838.3M | ||
| Q2 25 | $6.2B | $854.0M | ||
| Q1 25 | $5.9B | $888.3M | ||
| Q4 24 | $5.1B | $902.3M | ||
| Q3 24 | $5.3B | $908.2M | ||
| Q2 24 | $4.5B | $915.9M | ||
| Q1 24 | $4.6B | $923.4M |
总资产ADPNEO
| Q4 25 | $84.6B | $1.4B | ||
| Q3 25 | $54.3B | $1.4B | ||
| Q2 25 | $53.4B | $1.4B | ||
| Q1 25 | $56.4B | $1.6B | ||
| Q4 24 | $64.1B | $1.6B | ||
| Q3 24 | $49.5B | $1.6B | ||
| Q2 24 | $54.4B | $1.6B | ||
| Q1 24 | $64.2B | $1.6B |
负债/权益比ADPNEO
| Q4 25 | — | 0.41× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1B | $1.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-6.5M |
| 自由现金流率自由现金流/营收 | — | -3.4% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 1.07× | — |
| 过去12个月自由现金流最近4个季度 | — | $-21.8M |
8季度趋势，按日历期对齐
经营现金流ADPNEO
| Q4 25 | $1.1B | $1.3M | ||
| Q3 25 | $642.3M | $8.9M | ||
| Q2 25 | $1.4B | $20.3M | ||
| Q1 25 | $1.5B | $-25.3M | ||
| Q4 24 | $1.2B | $9.8M | ||
| Q3 24 | $824.4M | $9.2M | ||
| Q2 24 | $1.3B | $13.9M | ||
| Q1 24 | $1.5B | $-25.9M |
自由现金流ADPNEO
| Q4 25 | — | $-6.5M | ||
| Q3 25 | — | $570.0K | ||
| Q2 25 | — | $14.0M | ||
| Q1 25 | — | $-29.8M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | — | $-1.6M | ||
| Q2 24 | — | $814.0K | ||
| Q1 24 | — | $-31.5M |
自由现金流率ADPNEO
| Q4 25 | — | -3.4% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 7.7% | ||
| Q1 25 | — | -17.8% | ||
| Q4 24 | — | -1.0% | ||
| Q3 24 | — | -0.9% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | -20.2% |
资本支出强度ADPNEO
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | — | 6.4% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | — | 3.6% |
现金转化率ADPNEO
| Q4 25 | 1.07× | — | ||
| Q3 25 | 0.63× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 1.22× | — | ||
| Q4 24 | 1.19× | — | ||
| Q3 24 | 0.86× | — | ||
| Q2 24 | 1.57× | — | ||
| Q1 24 | 1.26× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADP
| HCM | $2.2B | 42% |
| PEO Zero Margin Benefits Pass Throughs | $1.1B | 21% |
| HRO | $979.3M | 18% |
| Global | $709.3M | 13% |
| Interest On Funds Held For Clients | $308.6M | 6% |
NEO
| Client Direct Billing | $133.4M | 70% |
| Commercial Insurance | $31.4M | 17% |
| Medicare And Other Governmental | $25.4M | 13% |
